ArticleNew microbes and new infections2020
Resistotyping and extended-spectrum beta-lactamase genes among
Article in New microbes and new infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 36 citations in OpenAlex.
- Article
- Environmental Dissemination of Multidrug-Resistant Gram-Negative Pathogens in Djibouti's Wastewaters.Public health challenges · 2025Article
- Characterization of multidrug-resistant Escherichia coli isolated from clinical (UPEC) and environmental samples.Molecular biology reports · 2025Article
- Prevalence of Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2025Article
- Sustainable water reuse in food production: risks of extended-spectrum β-lactamase (ESBL)-producingFrontiers in microbiology · 2025Article
- Article
- Surveillance of public health pathogens in Lagos wastewater canals: a cross-sectional study.BMC public health · 2024Article
- Enterobacterales Producing ESBLs and AmpC in Fresh Vegetables from Tebessa City, Algeria.Microbial drug resistance (Larchmont, N.Y.) · 2024Article
- Extended-spectrum beta-lactamase (ESBL)- and non-ESBL producing Escherichia coli surveillance in surface water sources in Edo State, Nigeria: a public health concern.Scientific reports · 2024Article
- Antibiotic resistance ofJournal of water and health · 2024Article
- Antimicrobial Resistance Profiles and Co-Existence of Multiple Antimicrobial Resistance Genes inAntibiotics (Basel, Switzerland) · 2023Article
- The African Wastewater Resistome: Identifying Knowledge Gaps to Inform Future Research Directions.Antibiotics (Basel, Switzerland) · 2023Review
- Surveillance on ESBL-Antibiotics (Basel, Switzerland) · 2023Article
- Antimicrobial resistance genes ofAIMS microbiology · 2023Review
- Clinically Relevant β-Lactam Resistance Genes in Wastewater Treatment Plants.International journal of environmental research and public health · 2022Review
- Carbapenem resistance associated with coliuria among outpatient and hospitalised urology patients.New microbes and new infections · 2022Article
- Similarities in Virulence and Extended Spectrum Beta-Lactamase Gene Profiles among Cefotaxime-ResistantAntibiotics (Basel, Switzerland) · 2022Article
- Inactivation of antibiotic-resistant bacteria and antibiotic-resistance genes in wastewater streams: Current challenges and future perspectives.Frontiers in microbiology · 2022Review
- Analysis of Wastewater Reveals the Spread of Diverse Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2021Article
- Extended Spectrum Beta-LactamaseTropical medicine and infectious disease · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spread of extended-spectrum β-lactamase (ESBL)-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.